CHICAGO–(BUSINESS WIRE)–RMB Capital (“RMB”), a Chicago-based independent investment advisory firm, is a long-term shareholder of Sanyo Shokai Ltd. (8011 JP, “Sanyo”) and owns more than 6% of the firm’s total outstanding shares.
The official disclosure from the 77th annual general shareholders meeting held at Sanyo on May 26, 2020 revealed that approximately 30% of the shareholders supported RMB’s board nominees, Mr. Tetsuo Komori and Mr. Masakazu Hosomizu, while rejecting the former president Mr. Masayuki Nakayama. It was clear that the general shareholders took a harsh view of Sanyo’s executives who are accountable for the company’s poor performance. Against this backdrop, RMB believes the new management team, led by Mr. Shinji Oe, should further accelerate the speed of the reform initiatives. Also, key Sanyo shareholders and trade partners, including Mitsui & Co, Yagi Tsusho, and Isetan Mitsukoshi, who RMB believes were supportive of management’s board slate, are now responsible for stepping forward and supporting Sanyo proactively so that the executive team can achieve its turnaround plan. RMB hopes all stakeholders collectively support Sanyo’s turnaround going forward.
Please refer to Sanyo Shokai Activism for RMB’s past press releases on this topic.
About RMB Capital
Headquartered in Chicago, RMB Capital is an independent investment advisory firm that serves high-net-worth individuals and families as well as institutional investors. Its businesses include wealth management, family office services, asset management, and retirement plan consulting. Its asset management business specializes in long-term, concentrated, active investing strategies with coverage that spans the market-cap spectrum and the globe. To learn more about RMB, visit https://rmbcapital.com.
Contacts
Media Contact:
Masakazu Hosomizu
RMB Capital
japan@rmbcap.com
SINGAPORE - Media OutReach Newswire - 29 April 2024 - From 26 April to 12…
SINGAPORE - Media OutReach Newswire - 29 April 2024 - XT, the world's first socially…
LONDON--(BUSINESS WIRE)--#BonteFriedheim--NextEnergy Capital (“NEC”), a leading global renewables manager specialised on the solar+ infrastructure sector,…
H2SITE’s AMMONIA to H2POWER technology for ammonia cracking on-board has received Approval in Principle (AiP)…
Daiichi Sankyo and AstraZeneca’s ENHERTU also demonstrated a clinically meaningful progression-free survival improvement in patients…
Q1 2024 Group sales at $7.4 billion, -20% (-18% at CER) versus prior year Q1…